MoneyWorks4Me

Indrayani Biotech - Quaterly Results

11 Aug 2023 Evaluate
The revenue for the June 2023 quarter is pegged at Rs. 168.19 millions, about 7.83% up against Rs. 155.98 millions recorded during the year-ago period.The Company to register a -42.27%  fall in the net profit for the quarter ended June 2023.Operating profit for the quarter ended June 2023 rose to 20.36 millions as compared to 17.49 millions of corresponding quarter ended June 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 168.19 155.98 7.83 168.19 155.98 7.83 744.80 579.89 28.44
Other Income 0.05 3.82 -98.69 0.05 3.82 -98.69 6.42 2.21 190.50
PBIDT 20.36 17.49 16.41 20.36 17.49 16.41 92.96 64.49 44.15
Interest 9.58 3.90 145.64 9.58 3.90 145.64 27.84 18.80 48.09
PBDT 10.78 13.59 -20.68 10.78 13.59 -20.68 60.12 45.69 31.58
Depreciation 3.61 1.17 208.55 3.61 1.17 208.55 9.33 3.44 171.22
PBT 7.17 12.42 -42.27 7.17 12.42 -42.27 50.79 42.25 20.21
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.22 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 7.17 12.42 -42.27 7.17 12.42 -42.27 50.57 42.25 19.69
Equity 342.27 342.27 0.00 342.27 342.27 0.00 342.27 342.27 0.00
PBIDTM(%) 12.11 11.21 7.96 12.11 11.21 7.96 12.48 11.12 12.23
Peers
Company Name CMP
Grasim Industries 2865.50
DCM Shriram 953.20
3M India 30307.30
Hindustan Foods 571.45
Balmer Lawrie & Co 157.25
View more..